Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Status:
Withdrawn
Trial end date:
2012-08-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of gabapentin on symptom control
in patients with defined functional dyspepsia refractory to conventional proton pump
inhibitor therapy and to compare these effects to that of placebo.